Swine Flu, 2009

Where are we?


I believe the genus epidemicus is still Nux vomica. I also believe that the genus epidemicus is morphing, adding symptoms as it changes. Note that these new symptoms are also common clinical symptoms of pneumonia. So what I believe happens in cases of infection with Swine Flu, is that some people are going deeper into the same homeopathic state. I also believe that this new set of symptoms is forming a bridge to a new remedy state, such that some people are in a more severe Nux vomica state while others may be moving past that into a new remedy state.  Many of you know what I refer to as a bridge, but think of it this way; you have a Venn diagram with two partially overlapping circles, with each circle representing individual, but related, remedies.  The overlap that these two circles share, which is actually an overlap of a discrete set of symptoms, represents the potential bridge between these remedies. In this case, the first circle is Nux vomica. What the swine flu shift has done is to cause an extension or enlargement of the intersecting bridge set of symptoms, and those that are getting sicker within this state are expressing new symptoms in this area. Others, however, are sick enough to shift into a new remedy state, using the fever and cough symptom set as the “bridge” to get there. That remedy may be one of several, which we will speak to later as a clearer picture emerges, but the bottom line is this: mortality rates are rising due to this new ‘extension’ of the previous flu symptoms.


Symptom Bridge







































What should we do?


I believe that the genus epidemicus is still Nux vomica. Therefore, if someone is sick with the flu, I would run through the Nux vomica questionnaire to determine whether they will respond to that remedy. (See "Flu Tools" section for a downloadable version of this) If they pass through that tool, then I would give Nux vomica 200C, 2 doses, one hour apart. Their improvement, then, should relate back to that circle; if the remedy is successful the circle shrinks, and in so doing the symptom set that forms the bridge to the next, more severe, remedy also shrinks, reducing the possibility that they move into a severe pneumonia. In addition, it is important to note that just as the remedy may shift via these bridging symptoms, so too may the disease itself shift. In this case, the influenza illness itself may predispose these patients to superinfections, like pneumonia, which then may express a unique symptomatic picture different from the genus epidemicus


Aside from that, as mentioned in our Herscu Letters 33-38 from a decade ago, please make sure that the patient’s constitutional remedy is still active, as this relates to their basic health and ability to respond effectively in influenza or other illness.  And of course, if the patient is acutely ill, doesn’t fit the Nux vomica picture, and doesn’t exhibit symptoms that fit within their chronic/constitutional remedy, consider whatever other remedy fits their current state.  For more information on these distinctions, see more info on the Herscu Letters 33-38 here.  


What we still need


There is still much detail from the current Swine Flu patients that we need to incorporate into our understanding of the situation.  What medical treatments are those who have died from Swine Flu being given, and what actually killed them?  Also, we need to know more about what the symptomatology is looking like in the latter part of the illness.  A frustrating aspect of this situation is the difficulty in getting these kinds of data, but the reason for this is that the CDC and WHO only track the most common symptoms of influenza.  As homeopaths, we need to understand a finer level of granulation in the patients’ symptomatic picture, and we must find a way to gain access to this data if we hope to be able to track and help treat the flu on a large scale.  This represents a major need in the area of cooperation between the conventional medical system and homeopathy.  Through clinical testing of tools like the Nux vomica questionnaire, we may be able to show the importance of a more detailed look at clinical symptomatology, and encourage this kind of data collection in a more standardized way.